Causal association of antibody-mediated immune responses to infectious disease agents with lung cancer: a Mendelian randomization study
Abstract Background There is a causal relationship between many non-communicable diseases and other infectious diseases. However, the exact relationship between lung cancer and the immune response to antibodies associated with viral diseases is unclear. Compared with other traditional methods, Mende...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02997-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849399765396094976 |
|---|---|
| author | Guicai Liang Lyubo Wang Zhiqiang Wang Tao Li Lei Jiang Yuncheng Bai Lei Yang Yi Feng Yan Li Meng Yang Jiling Chang Haiyue Yang Xilong Zhou Lincan Duan Chunlei Ge |
| author_facet | Guicai Liang Lyubo Wang Zhiqiang Wang Tao Li Lei Jiang Yuncheng Bai Lei Yang Yi Feng Yan Li Meng Yang Jiling Chang Haiyue Yang Xilong Zhou Lincan Duan Chunlei Ge |
| author_sort | Guicai Liang |
| collection | DOAJ |
| description | Abstract Background There is a causal relationship between many non-communicable diseases and other infectious diseases. However, the exact relationship between lung cancer and the immune response to antibodies associated with viral diseases is unclear. Compared with other traditional methods, Mendelian randomization (MR) studies reduce the influence of confounding factors, thus improving the accuracy of the results. This study used MR to investigate the relationship between lung cancer and its subtypes, and the antibody immune response. Methods A two-sample MR method was employed to examine the association between lung cancer, its subtypes, and antibody-mediated immunity linked to 46 infectious diseases. The instrumental variables were single nucleotide polymorphisms associated with lung cancer and its subtypes. Various MR methods were used to study the causal relationship between lung cancer risk and exposure, including weighted median, MR-Egger regression, inverse variance weighting, simple model and simple median methods. In addition, immunocytological analyses were performed on lung cancer and its subtypes. Results This study investigated the relationship between lung cancer and antibodies to varicella zoster glycoproteins I and E. This indicates that the level of these antibodies is a risk factor for lung cancer. The levels of antibodies to human herpes virus 7 U14, varicella zoster virus glycoproteins I and E, and anti-polyoma virus 2 were found to be related to squamous cell carcinoma, indicating a risk factor for lung cancer. Furthermore, the antibody levels of Epstein–Barr virus EBNA1 and Epstein–Barr virus VCA p18 were found to be related to lung squamous cell carcinoma and act as a protective factor. Another causal relationship was noted between small cell lung cancer and Epstein–Barr virus ZEBRA antibody levels, identifying ZEBRA as a risk factor. Leave-one-out sensitivity analysis and pleiotropy tests confirmed the stability of the results. Meanwhile, differences in the distribution of immune cells between different lung cancer subtypes provide further support for the MR results. Conclusion This study established a causal relationship between infectious disease-related antibody immune responses and lung cancer and its subtypes via genetic methods, increasing the understanding of the role of infectious disease-related antibody immune responses in lung cancer. |
| format | Article |
| id | doaj-art-5b7278439ab34d56ac20afd1bb640049 |
| institution | Kabale University |
| issn | 2730-6011 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Springer |
| record_format | Article |
| series | Discover Oncology |
| spelling | doaj-art-5b7278439ab34d56ac20afd1bb6400492025-08-20T03:38:15ZengSpringerDiscover Oncology2730-60112025-07-0116111910.1007/s12672-025-02997-zCausal association of antibody-mediated immune responses to infectious disease agents with lung cancer: a Mendelian randomization studyGuicai Liang0Lyubo Wang1Zhiqiang Wang2Tao Li3Lei Jiang4Yuncheng Bai5Lei Yang6Yi Feng7Yan Li8Meng Yang9Jiling Chang10Haiyue Yang11Xilong Zhou12Lincan Duan13Chunlei Ge14Cancer Biotherapy Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital YunnanCardiothoracic Surgery Department, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital YunnanDepartment of Radiation Oncology, The First Affiliated Hospital of Kunming Medical UniversityCancer Biotherapy Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital YunnanCancer Biotherapy Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital YunnanDepartment of Orthopedic Surgery, The First People’s Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and TechnologyDepartment of Oncology, The People′s Hospital of Dehong Prefecture, Dehong Hospital Affiliated to Kunming Medical UniversityCancer Biotherapy Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital YunnanDepartment of Radiation Oncology, The First Affiliated Hospital of Kunming Medical UniversityCancer Biotherapy Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital YunnanCancer Biotherapy Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital YunnanCancer Biotherapy Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital YunnanCancer Biotherapy Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital YunnanPuer City People’s HospitalCancer Biotherapy Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital YunnanAbstract Background There is a causal relationship between many non-communicable diseases and other infectious diseases. However, the exact relationship between lung cancer and the immune response to antibodies associated with viral diseases is unclear. Compared with other traditional methods, Mendelian randomization (MR) studies reduce the influence of confounding factors, thus improving the accuracy of the results. This study used MR to investigate the relationship between lung cancer and its subtypes, and the antibody immune response. Methods A two-sample MR method was employed to examine the association between lung cancer, its subtypes, and antibody-mediated immunity linked to 46 infectious diseases. The instrumental variables were single nucleotide polymorphisms associated with lung cancer and its subtypes. Various MR methods were used to study the causal relationship between lung cancer risk and exposure, including weighted median, MR-Egger regression, inverse variance weighting, simple model and simple median methods. In addition, immunocytological analyses were performed on lung cancer and its subtypes. Results This study investigated the relationship between lung cancer and antibodies to varicella zoster glycoproteins I and E. This indicates that the level of these antibodies is a risk factor for lung cancer. The levels of antibodies to human herpes virus 7 U14, varicella zoster virus glycoproteins I and E, and anti-polyoma virus 2 were found to be related to squamous cell carcinoma, indicating a risk factor for lung cancer. Furthermore, the antibody levels of Epstein–Barr virus EBNA1 and Epstein–Barr virus VCA p18 were found to be related to lung squamous cell carcinoma and act as a protective factor. Another causal relationship was noted between small cell lung cancer and Epstein–Barr virus ZEBRA antibody levels, identifying ZEBRA as a risk factor. Leave-one-out sensitivity analysis and pleiotropy tests confirmed the stability of the results. Meanwhile, differences in the distribution of immune cells between different lung cancer subtypes provide further support for the MR results. Conclusion This study established a causal relationship between infectious disease-related antibody immune responses and lung cancer and its subtypes via genetic methods, increasing the understanding of the role of infectious disease-related antibody immune responses in lung cancer.https://doi.org/10.1007/s12672-025-02997-zAntibody-mediated immune responses to infectious disease agentsLung cancerMendelian randomizationGenome-wide association studies |
| spellingShingle | Guicai Liang Lyubo Wang Zhiqiang Wang Tao Li Lei Jiang Yuncheng Bai Lei Yang Yi Feng Yan Li Meng Yang Jiling Chang Haiyue Yang Xilong Zhou Lincan Duan Chunlei Ge Causal association of antibody-mediated immune responses to infectious disease agents with lung cancer: a Mendelian randomization study Discover Oncology Antibody-mediated immune responses to infectious disease agents Lung cancer Mendelian randomization Genome-wide association studies |
| title | Causal association of antibody-mediated immune responses to infectious disease agents with lung cancer: a Mendelian randomization study |
| title_full | Causal association of antibody-mediated immune responses to infectious disease agents with lung cancer: a Mendelian randomization study |
| title_fullStr | Causal association of antibody-mediated immune responses to infectious disease agents with lung cancer: a Mendelian randomization study |
| title_full_unstemmed | Causal association of antibody-mediated immune responses to infectious disease agents with lung cancer: a Mendelian randomization study |
| title_short | Causal association of antibody-mediated immune responses to infectious disease agents with lung cancer: a Mendelian randomization study |
| title_sort | causal association of antibody mediated immune responses to infectious disease agents with lung cancer a mendelian randomization study |
| topic | Antibody-mediated immune responses to infectious disease agents Lung cancer Mendelian randomization Genome-wide association studies |
| url | https://doi.org/10.1007/s12672-025-02997-z |
| work_keys_str_mv | AT guicailiang causalassociationofantibodymediatedimmuneresponsestoinfectiousdiseaseagentswithlungcanceramendelianrandomizationstudy AT lyubowang causalassociationofantibodymediatedimmuneresponsestoinfectiousdiseaseagentswithlungcanceramendelianrandomizationstudy AT zhiqiangwang causalassociationofantibodymediatedimmuneresponsestoinfectiousdiseaseagentswithlungcanceramendelianrandomizationstudy AT taoli causalassociationofantibodymediatedimmuneresponsestoinfectiousdiseaseagentswithlungcanceramendelianrandomizationstudy AT leijiang causalassociationofantibodymediatedimmuneresponsestoinfectiousdiseaseagentswithlungcanceramendelianrandomizationstudy AT yunchengbai causalassociationofantibodymediatedimmuneresponsestoinfectiousdiseaseagentswithlungcanceramendelianrandomizationstudy AT leiyang causalassociationofantibodymediatedimmuneresponsestoinfectiousdiseaseagentswithlungcanceramendelianrandomizationstudy AT yifeng causalassociationofantibodymediatedimmuneresponsestoinfectiousdiseaseagentswithlungcanceramendelianrandomizationstudy AT yanli causalassociationofantibodymediatedimmuneresponsestoinfectiousdiseaseagentswithlungcanceramendelianrandomizationstudy AT mengyang causalassociationofantibodymediatedimmuneresponsestoinfectiousdiseaseagentswithlungcanceramendelianrandomizationstudy AT jilingchang causalassociationofantibodymediatedimmuneresponsestoinfectiousdiseaseagentswithlungcanceramendelianrandomizationstudy AT haiyueyang causalassociationofantibodymediatedimmuneresponsestoinfectiousdiseaseagentswithlungcanceramendelianrandomizationstudy AT xilongzhou causalassociationofantibodymediatedimmuneresponsestoinfectiousdiseaseagentswithlungcanceramendelianrandomizationstudy AT lincanduan causalassociationofantibodymediatedimmuneresponsestoinfectiousdiseaseagentswithlungcanceramendelianrandomizationstudy AT chunleige causalassociationofantibodymediatedimmuneresponsestoinfectiousdiseaseagentswithlungcanceramendelianrandomizationstudy |